Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

OXPHOS inhibitors: a novel class of oncology therapeutics

April 29, 2014

ATG5, COL1A1 and CAV1 polymorphisms associated with esophageal cancer prognosis

April 29, 2014

MiR-296 presented as a prognostic and predictive molecular biomarker for laryngeal carcinoma

April 28, 2014

PAR-1 antagonist F-16357 dose-dependently inhibits bladder contraction

April 28, 2014

AbbVie presents A-366, an inhibitor of G9a/GLP

April 28, 2014

Genentech LDH-A inhibitor targets glycolysis in tumors

April 28, 2014

IO-125 supramolecular oxaliplatin analogue shows improved anticancer efficacy

April 28, 2014

Mitomycin C gel formulation may enhance topical efficacy in urothelial cancer

April 25, 2014

Daclatasvir/asunaprevir/BMS-791325 combination evaluated in genotype 4 HCV

April 25, 2014

Acerta Pharma presents preclinical data for ACP-196

April 25, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...